Cargando…
Function and Modulation of Type I Interferons during Respiratory Syncytial Virus Infection
Respiratory syncytial virus (RSV) is the leading cause of lower respiratory infections in infants and young children, accounting for an estimated 3 million hospitalizations annually worldwide. Despite the major health burden, there is currently no licensed RSV vaccine. RSV is recognized by a range o...
Autores principales: | Stephens, Laura M., Varga, Steven M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349809/ https://www.ncbi.nlm.nih.gov/pubmed/32290326 http://dx.doi.org/10.3390/vaccines8020177 |
Ejemplares similares
-
Considerations for a Respiratory Syncytial Virus Vaccine Targeting an Elderly Population
por: Stephens, Laura M., et al.
Publicado: (2021) -
Type I Interferon Potentiates IgA Immunity to Respiratory Syncytial Virus Infection During Infancy
por: Hijano, Diego R., et al.
Publicado: (2018) -
Alveolar Macrophages Can Control Respiratory Syncytial Virus Infection in the Absence of Type I Interferons
por: Makris, Spyridon, et al.
Publicado: (2016) -
Cytokines and CD8 T cell immunity during respiratory syncytial virus infection
por: Schmidt, Megan E., et al.
Publicado: (2020) -
Role of Type I Interferon (IFN) in the Respiratory Syncytial Virus (RSV) Immune Response and Disease Severity
por: Hijano, Diego R., et al.
Publicado: (2019)